A type of genetic variation within a DNA sequence. It occurs when a single nucleotide (for example, thymine) replaces one of the other three nucleotides (for example, cytosine).
More than twelve different human behavioural traits and whole-body medical disorders are reported to be associated with serotonin transporter (SERT) gene (SLC6A4) variation. Reduced transporter expression and function resulting from variation in the gene's major transcriptional control region (the serotonin-transporter-gene-linked polymorphic region (5-HTTLPR)) is associated with anxiety-and depression-related personality traits 1 . Similarly, the 5-HTTLPR and other regulatory and structural variations (in the non-coding and coding regions, respectively) seem to have a role in neuropsychiatric conditions such as bipolar disorder, depression, anxiety disorders (especially obsessive-compulsive disorder), suicide, eating disorders, substance-abuse disorders, autism, attention-deficit/hyperactivity disorder and neurodegenerative disorders [2] [3] [4] [5] . In addition, therapeutic responses and side effects following treatment with selective serotonin-reuptake inhibitors (SSRIs) have been found to be associated with SLC6A4 variants 6 . Other disorders with SLC6A4 associations include myocardial infarction, pulmonary hypertension, irritable bowel syndrome and sudden infant death syndrome (SIDS) 4 . Although each of these findings has been replicated at least once or supported by recent meta-analyses 4,7-9 , uncertainties remain about the biological bases for the associations 3,4 .
Human SLC6A4 maps to chromosome 17q11.2 and is composed of 14 exons that span ∼40 kb (FIG. 1a) . The sequence of the transcript predicts a protein made up of 630 amino acids with 12 transmembrane domains. Alternative promoters, differential splicing involving exons 1A, 1B and 1C, and 3′-untranslated-region variability resulting in multiple mRNA species are likely to regulate expression of the gene in humans (FIG. 1a) . The transcriptional activity of SLC6A4 is modulated by a variation in the length of the 5-HTTLPR together with two single nucleotide polymorphisms (SNPs) in this region, rs25531 and rs25532, all of which are located upstream of the transcription start site 1,2 (FIG. 1a) . Additional variants at the SLC6A4 locus include a variable number of tandem repeats (VNTR) polymorphism in functional intron 2 and several other SNPs that change the structure or function of the transporter protein 1,10-12 . Most of these SNPs are rare, but the rs25531 polymorphism has a minor-allele frequency of 9-15% in Caucasians and 24% in African Americans and interacts with the 5-HTTLPR to affect SLC6A4 transcription (FIG. 1c) 2,13 . Several of the lesscommon SNPs and their haplotypes are associated with behavioural phenotypes or disorders, including obsessive-compulsive disorder and autism 2,10-12, [14] [15] [16] . To explore the question of what genetic disorders might be attributable to life-long SLC6A4 
Extinction recall
A unique learning and recall process, mostly studied with fear conditioning, that requires the alteration of stimulusresponse associations such that the organism ceases to respond to a previously rewarded stimulus.
dysfunction, mice with reduced or completely abrogated SERT protein following targeted disruption of Slc6a4 were generated 17 , revealing a remarkable phenotypic pleiotropy (BOX 1; FIG. 2) . Additional genetic engineering tools were used in subsequent investigations of Slc6a4, and produced consequences that were largely consistent with those of the original studies of the constitutive-knockout mice [18] [19] [20] [21] (FIG. 2) . Many of these effects can now be understood on the basis of specific developmental, neurochemical, receptorsignalling and other molecular consequences of Slc6a4 inactivation. In this Review we describe the remarkable extent of pleiotropy in these mice and discuss the underlying mechanisms. we also provide some thoughts on the relevance of these observations to human and non-human primate neurobiology, evolution, behaviour, gene-environment interactions and neuropsychiatric disorders.
Phenotypes of Slc6a4-mutant mice Anxiety-like behaviours. Various approaches have been used to experimentally alter Slc6a4 expression and SERT function in mice, including the constitutive Slc6a4 knockout reviewed here (FIG. 2) . The 5-HTTLPR short variant, which results in lower expression of SLC6A4, is strongly associated with anxiety-related, harm-avoidant and negative personality traits in humans 1, 3, 7, 8, 22 . Slc6a4
and Slc6a4 -/-mice were therefore predicted to exhibit increased anxiety-like behaviours. This was indeed found to be the case, according to multiple measures, in both male and female Slc6a4 -/-mice with different genetic backgrounds [23] [24] [25] . Gender differences and an intermediate phenotype in heterozygote mice have also been observed [18] [19] [20] [24] [25] [26] . After mild postnatal foot-shock stress experiences 27 or exposure to predator odours 28 , anxiety-like behaviours are intensified in Slc6a4 -/-mice but not in wild-type mice. Latent anxiety-like behaviours Figure 1 | organization of the human serotonin transporter (serT) gene (SLC6A4). a | The structure of the SLC6A4 gene, including the sites of the major functional variants: the serotonin-transporter-gene-linked polymorphic region (5-HTTLPR), the variable number of tandem repeats (VNTR) (between 9 and 12 repeats can be found in intron 2 (STin2)) and the single nucleotide polymorphisms (SNPs) . b | Relative potential additive SERT expression and function for the major SLC6A4 polymorphisms. There is a theoretical 4.65-fold difference in function between individuals with a combination of the less active allele of each variant and individuals with the most active variants 1,2,4,10,11
. The left-most two bars bars depict the actual differences in SERT expression and function that were measured in human lymphoblasts from large numbers of individuals, with the light-blue bar representing the 5-HTTLPR short/short (SS) + rs25531 genotype and the yellow bar representing the 5-HTTLPR long/long (LL) + rs25531 genotype; the six bars on the right combine this information with the functional consequences of the additional variants (G56A, I425V and STin2) that are predicted from in vitro measurements (dark-blue segments). c | The SERT protein, with its 12 transmembrane (TM) segments, its extracellular loops and its intracellular amino-and carboxy-terminal tails. SNPs that change amino acids are denoted by red circles (except the functionally validated G56A and I425V SNPs, which are coloured yellow); those in blue are synonymous. Panels a and c modified, with permission, from 
Genomic imprinting
For most autosomal genes expression occurs from either allele, whereas a small proportion (<1%) of genes are imprinted, meaning that expression occurs from only one allele. Which of the two alleles is expressed is dependent on the parental origin.
have also been reported in Slc6a4 +/-mice that experience poor maternal care; brain-derived neurotrophic factor (BDNf) has been identified as the molecular substrate of the epigenetic programming that causes these effects 29 .
Repeated stressful experiences in adult Slc6a4
-/-mice lead to deficits in extinction recall following fear conditioning and to depression-like behaviour 30 . These mice also develop changes in the dendritic morphology and spine density of pyramidal neurons in their infralimbic cortex and basolateral amygdala 30 . finally, mice treated with the SSRI fluoxetine during early development also exhibit increased anxiety-like behaviour as well as other related behaviours that include avoidance of open-field exposure 18, 31 . when SERT-deficient mice are interbred with mice that lack one copy of the BDNf gene, the anxiety-like behaviours and tissue serotonin depletion intensify, in keeping with data that show that BDNf is required for the development and maintenance of the brain's serotonin system 32 . Interestingly, a marked reduction in anxiety-like behaviours was found in transgenic mice generated using a human yeast artificial chromosome (yAC) construct that causes a two-to threefold overexpression of SERT and reduced extracellular serotonin concentrations. This appears to confirm a direct relationship between serotonin availability and anxiety-related behaviours 21 .
The anxiety-like behaviour in the Slc6a4
+/-and Slc6a4 -/-mice can be normalized by the serotonin 1A receptor (5-HT 1A receptor) antagonist wAy 100635, suggesting that the postsynaptic 5-HT 1A receptor is a participant in these anxiety-like behaviours 24 .
Somatosensory cortex and the whisker barrel pathway. Cytoarchitectonic changes are found in the barrelfield layer IV cortex of Slc6a4 -/-and Slc6a4 +/-mice, and gene dose-dependent reductions in the density of the barrel images has also been observed 33, 34 . Similar changes are also found in mice that lack the gene that codes for monoamine oxidase A (MAOA), an enzyme that is involved in the metabolism of serotonin 34 . To evaluate whether these morphological changes were of functional importance, responses to whisker stimulation in cortical barrelfields were investigated using local cerebral glucose-utilization measurements 35 . In wild-type mice, unilateral stimulation of whiskers leads to a significant glucose-utilization response in the contralateral somatosensory cortex. The magnitude of this response is significantly reduced in Slc6a4 -/-mice, and this reduction is also observed in other components of the trigeminal pathway and other somatosensory pathways that connect to the barrelfields 35 .
Rescue of cortical barrel architecture abnormalities in

Slc6a4
-/-and Slc6a4 +/-mice can be accomplished by treatment with the serotonin-synthesis inhibitor parachlorophenylalanine (PCPA) in a narrow developmental time window between postnatal day 1 and postnatal day 2 (REF. 33 ). Partial genetic rescue also occurs following inactivation, in this cortical area, of Htr1b, which encodes the serotonin 1B receptor 34 (5-HT 1B receptor).
Neuroendocrine and sympathoadrenal responses to stress. Slc6a4 -/-and Slc6a4 +/-mice have reduced basal plasma corticosterone levels but respond to acute stress with greater than normal levels of adrenocorticotropic hormone (ACTH) and oxytocin release [36] [37] [38] [39] 122, 123 . What is striking about the Slc6a4 knockout is its minimal impact on anatomical development. By contrast, in the other examples there is a relative lack of evident associated behavioural, neurological and other neurobiological abnormalities. When evolutionary selection occurs on the basis of improved fitness, the general conception has been that the naturally selected mutational variant of the gene relates to a single phenotype that is benefitted. The presence of more than one trait that is influenced by a gene product does not pose a problem, as long as all traits are equally benefitted. It is not yet clear whether this is the situation for the consequences of spontaneous human SLC6A4 variation or for engineered murine Slc6a4 variation. Alternate possibilities are that the phenotypes do not affect fitness (termed neutral pleiotropy), have opposing and equal contributions (antagonistic pleiotropy) or have consequences only after sexual maturity is reached 124, 125 . Some population biologists favour the view that evolutionary adaptations result from substitutions of single genes, with large effects 126, 127 . However, more common views of phenotypic divergence favour very small changes in many genes 124, 128 . In the face of this enormous pleiotropy in the Slc6a4-modified mouse, an obvious question is why there is only one serotonin transporter. SLC6A4's amino-acid coding structure is highly conserved 4 , and the divergence of even the most closely related transporters (for dopamine and noradrenaline) appears to pre-date vertebrate speciation, suggesting that these transporters are at least as far from human serotonin transporter (SERT) in evolution as Drosophila melanogaster or Caenorhabditis elegans SERT 4 . What has constrained the evolution of SERT? A few theorists have discussed how trait variation would be evolutionarily constrained by pleiotropy 124, 129 . Thus, although any two traits can be complimentary, some traits have been found to be or have been considered to be antagonistic, and are therefore subject to selection pressures that act on each one separately. In other words, the sheer number of consequences that arise from any functional genetic variation in SERT or similar molecules would be expected to decrease overall fitness and thus reduce the survival of the new genetic variant. Nature Reviews | Neuroscience 
Isolated-resident/intruder test
A test for social interaction and offensive aggressive behaviour in rodents. An unfamiliar mouse (the 'intruder') is introduced into the cage of a mouse that has been kept isolated in its 'resident' cage for several months.
noradrenaline and serotonin in the adrenal glands, and pituitary tissue ACTH is also significantly reduced 43 . These differences suggest that one function of SERT is to restrain adrenomedullary activation in response to severe stress 44 . The usual increase in tyrosine-hydroxylase transcription and adrenomedullary angiotensin-IIreceptor expression that follows adrenal adrenaline and noradrenaline release in response to restraint and other forms of stress does not occur in Slc6a4 -/-mice 45 . Thus, exaggerated adrenomedullary responses seem to be an autonomic correlate of the anxiety-like behaviours and exaggerated hypothalamo-pituitary responses that occur in Slc6a4 -/-mice [43] [44] [45] .
Aggression. Slc6a4 -/-mice are less aggressive than control mice in the isolated-resident/intruder test 46 . Additionally,
Slc6a4
-/-and Slc6a4 +/-mice fail to shorten the latency time to first attack in a second intruder-encounter experiment, unlike wild-type mice. This confirms a role for altered SERT levels in aggressive behaviours and indicates that Slc6a4 -/-and Slc6a4 +/-mice have altered emotional learning in comparison with wild-type mice. The findings might also be related to other socialinteraction deficits in the Slc6a4 -/-and Slc6a4 +/-mice and suggest that these mice might be a useful model of some aspects of social anxiety and autism 46, 47 . Reports of altered aggression in mice with a deletion of one Bdnf allele suggest that studies of Slc6a4 × Bdnf doublemutant mice might provide further evidence of specific epistasis that is similar to that which is observed for anxiety-like behaviours and neuroendocrine responses in these mice 40, 48, 49 .
Sleep, brain excitability, body temperature and gut motility. Slc6a4 -/-and Slc6a4 +/-mice have substantially increased rapid eye movement (REM) sleep time 50 . furthermore, brain excitability (as reflected in their susceptibility to pentylenetetrazole-induced seizures) is reduced in these mice 51 , whereas baseline body temperature is increased 52 . Gut physiological function is also abnormal in Slc6a4 -/-mice, which have increased colonic motility and other symptoms that resemble the symptoms of human irritable bowel syndrome 53 . These changes have also been found to accompany the serotonin-precursor (5-hydroxytryptophan; 5-HTP)-induced serotonin syndrome 54 .
Sensory, bladder and vascular function. Sensory function is reduced in Slc6a4
-/-mice, as reflected by their reduced spinal reflexes and reduced responses to mildly painful thermal or nerve-crush injuries 49, 55 . Likewise, bladder responses to stretching are reduced in female Slc6a4 -/-mice 56 . However, basic neurological and motor testing reveals no overt changes in other reflexes, including the eye-blink, whisker and righting reflexes 46 . Both blood plasma and platelets are devoid of serotonin in Slc6a4 -/-mice 53, 57 . furthermore, most peripheral organs have markedly depleted serotonin levels, confirming that the normal presence of serotonin in most peripheral tissues is dependent on SERT 58 . The elevated blood pressure that normally develops in response to reduced oxygen availability at simulated high altitudes is reduced or absent in Slc6a4 -/-mice. This might provide an explanation for the protection against the development of human pulmonary hypertension that is apparently afforded by the lesser-expressing short allele and short/short genotype of the 5-HTTLPR 4,57 . Also, Slc6a4 -/-mice display lower left cardiac ventricular weight relative to body weight and develop cardiac fibrosis as well as valvulopathy 57, 59 . Thus, serotonin and SERT have a role not only in visceral function but also in cardiovascular and respiratory function.
Bone and muscle strength, and agility. The ability to cling to a wire-mesh screen (a test of strength) and to maintain a grasp on a rotating metal rod is reduced in Slc6a4 -/-mice 46 . Likewise, bone weight, thickness and structural resistance to fracture in vitro are also significantly reduced 60, 61 . One plausible basis for these impairments is the lifetime reduction in physical activity and exercise that results from reduced horizontal, vertical and risk-assessment behaviours (including standing and surveying and sniffing the environment) in SERTdeficient mice 46, 62 . There do not appear to have been any The sites and strategies of the four major genetic modifications that have been performed, along with the resulting effects on SERT expression and function, are illustrated and summarized in the text boxes. a | For the constitutive knockout, two similar targeting constructs directed towards exon 2 of Slc6a4 (the deleted region was replaced with a neo cassette) have been used to disrupt the gene, both resulting in a complete abrogation of brain SERT protein and labelled-ligand binding to SERT (that is, an abrogation of SERT binding sites) 17, 18 . b | In addition, a reduction or complete abrogation of SERT has been achieved using a gene-trap approach that replaced exon 14 with a non-functional sequence 20 . c | Short-interfering RNA (siRNA) has also been used to partially reduce (knockdown) SERT levels 19 . d | Finally, a human yeast artificial chromosome (YAC) construct that resulted in a two-to threefold overexpression of SERT and a reduction in extracellular serotonin concentrations has also been created 21 . e | Also shown is one theoretical model of how SERT components might insert into the lipid bilayer membrane to yield cross-membrane facilitated transport. Nature Reviews | Neuroscience Genotype Genotype
Epistasis
A characteristic of the interactions between two or more genetic loci. Negative epistasis occurs when the combined phenotypic effect of two or more loci is less than the sum of the effects at individual loci, whereas positive epistasis occurs when the combined effect of the two or more loci is greater than the sum at individual loci.
Rapid eye movement (REM) sleep
The period of sleep during which dreaming is thought to occur. REM sleep is characterized by increased brain-wave activity, bursts of rapid eye movement, accelerated respiration and heart rate, and muscle relaxation to the point of paralysis.
comparable evaluations of the effect of human SLC6A4-variant associations on physical fitness or strength. However, similar results would be predicted from the observations in Slc6a4 -/-and Slc6a4 +/-mice, particularly because reductions in bone mineral density are found in humans receiving SSRI treatment 63, 64 . Body weight, locomotor activity and obesity. An obesity phenotype emerges in Slc6a4 -/-mice at approximately 3 months of age and becomes more exaggerated throughout life 62, 65 (FIG. 3a,b) . Obesity is associated with increased plasma levels of insulin and leptin 62 (FIG. 3c,d ).
Obese adult Slc6a4
-/-mice also exhibit hyperglycaemia (despite normal glucose clearance) and reduced basal corticosterone levels. Plasma triglycerides and cholesterol are also elevated in Slc6a4 -/-mice, and preliminary data indicate the presence of insulin resistance, as reflected by the smaller-than-normal glucose reductions that occur following insulin administration (Holmes, A. and D.L.M., unpublished observations). Daily food consumption is normal in Slc6a4 -/-mice, indicating that the obesity is not simply dietary in origin 46 . Indeed, daily home-cage locomotor activity (measured concomitantly with food consumption) is lower in both pre-obese and obese Slc6a4 -/-mice 26, 46 . These observations contrast with the normal motor activity that is observed in other laboratory assessments, including habituation to the apparatus 17, 66 . This obesity phenotype resembles that of type 2 diabetes with obesity -'metabolic syndrome' -in humans. The lack of hyperphagia and lack of differential response to a high-fat diet, together with normal metabolic function, suggest that reduced serotonin signalling affects the development of obesity through reduced motor activity -a 'couch potato' syndrome. However, a confirmed basis for the locomotor-activity deficit is unknown at present, as are the potential contributions of some endocrine and other metabolic factors 67, 68 .
Responses to drugs. Many pharmacologic agents that act through SERT (including 3,4-methylenedioxymethamphetamine (MDMA), 2′-NH 2 -1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (2′-NH 2 -MPTP) and SSRIs) or through serotonin receptors (including 8-hydroxydipropylaminotetralin (8-OH-DPAT), Ru24969 and 2,5-dimethoxy-4-iodoamphetamine (DOI)) have reduced efficacy in Slc6a4 -/-and Slc6a4 +/-mice, reflecting the reduced availability or downregulated function of these drug targets 17, 37, 46, 51, 69, 70 . MDMA self-administration is absent in Slc6a4 -/-mice, and alcohol preference and ingestion are reduced (although alcohol's sedative effects are increased) [71] [72] [73] [74] . By contrast, cocaine preference is enhanced in Slc6a4 -/-and Slc6a4 +/-mice 75 . However, in Slc6a4-mutant mice that have been interbred with mice that lack the dopamine transporter, cocaine preference is abolished 66, 75 . Behavioral changes and large changes in body temperature that result from treatment with 5-HT alone or 5-HT and monoamine oxidase inhibitors occur as components of exaggerated serotonin syndrome in Slc6a4 -/-and Slc6a4 +/-mice. These behavioural changes encompass a wide range of cognitive, autonomic and somatic features 76, 77 . They suggest that humans carrying the lesser-expressing 5-HTTLPR short variant could be at a higher risk for developing the human serotonin syndrome 77 .
Slc6a4-mutant-phenotype mechanisms
The basis of SERT pleiotropy. An overview of the multiple phenotypes that are observed in Slc6a4 -/-and Slc6a4 +/-mice is provided in FIG. 4 , together with a comprehensive summary of the directions of the experimental differences that are seen in these mice compared with wild-type mice. One evident basis for these multiple changes is the anatomy of the serotonin system, which is best considered as four interacting subsystems (FIG. 5b) . Of these, the serotonin subsystem in the CNS has been the most comprehensively studied (FIG. 5a) . Cell bodies in the raphe nuclei provide modulatory serotonergic input to multiple neuronal circuits in the brain through the midbrain and upper pons cell groups, plus input to the spinal cord from its brainstem caudal cell groups (FIG. 5a) . In the periphery, a partially separate serotonergic enteric neural system (ENS) exists within the gut 78, 79 and interacts with other CNS and peripheral serotonergic mechanisms (FIG. 5b) . furthermore, several other tissues without any prominent serotonergic innervations (such as lung, heart, blood-vessel and pancreatic tissue, as well as platelets) contain functional SERT. These tissues normally take up and store serotonin in vesicles, and can release it in response to local stimuli. Thus, they can be considered to be a peripheral serotonergic system. A neuroendocrine serotonergic 
bottom). c,d | Plasma leptin and insulin concentrations are higher in Slc6a4
-/-and Slc6a4 +/-mice than in control mice. *, significant change; **, highly significant change. Data from REF. 62 .
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Slc6a4
-/-and Slc6a4 +/-mice: overview of major phenotypes 17, 58 . These abnormalities act in somewhat different ways during development (when serotonin has neurotrophic and morphogenic effects 80 ) and in adulthood (when the continuing excess of extracellular serotonin seems most important). Thus, this pleiotropy (BOX 1) can be considered to result from several distinct or overlapping pathways. furthermore, there are possible differences in pathway formation that lead to different pleiotropic consequences based on developmental timelines: for example, the same reductions in SERT function might lead to independent and different consequences in the brain (for example, anxiety-like behaviours) and in the gut (for example, hypermotility) -this would be 'true' pleiotropy. Alternatively, the consequences of SERT dysfunction in the brain might cause or contribute to gut hypermotility directly, possibly through increased anxiety. Less likely, but conceivably, gut dysfunction might cause or contribute to brain and behaviour dysfunction, 
B1
Serotonin syndrome
An uncommon but potentially life-threatening adverse drug reaction that is caused by excess serotonergic activity at CNS and peripheral serotonin receptors. It can result from intentional self-poisoning, therapeutic drug use or inadvertent interactions between drugs such as SSRIs and monoamine oxidase inhibitors. It can also occur spontaneously in a mild form in Slc6a4 -/-mice, and Slc6a4 -/-and Slc6a4 +/-mice are more susceptible to developing the syndrome following the administration of relatively low doses of many drugs.
including anxiety. Of course, different mechanisms might also coexist and interact. Likewise, such interactive mechanisms, possibly involving allelic variation of SERT function, have also been postulated in multiple studies of humans, as illustrated by one recent twin study that directly examined the basis for the well-documented cooccurrence of SERT-variation-related mood disorders and coronary artery disease 81, 82 . Neurochemical characteristics. Basal extracellular fluid serotonin concentrations are markedly increased in the striatum and cortex of Slc6a4 +/-and Slc6a4 -/-mice 83 . Serotonin clearance in the CA3 region of the hippocampus is prolonged in Slc6a4 -/-mice, to the point where its removal cannot be distinguished from diffusion alone, and is prolonged to an intermediate extent in
Slc6a4
+/-mice 73, 83 . These markedly increased extracellular serotonin concentrations thus amplify and extend the duration of serotonin signalling at serotonin receptors, significantly altering the functional state of the entire serotonin system.
In contrast to the extracellular fluid levels, serotonin brain-tissue concentrations are decreased by 40-60% in Slc6a4 -/-mice; furthermore, serotonin concentrations are reduced to <10% of normal in most peripheral tissues where serotonin is not synthesized 17, 38, 43, 58 . In all of these tissues, and in others that express SERT, the reductions in tissue serotonin content seem to be a direct result of a failure of this specific SERT-mediated uptake system, with a lack of or inadequate compensation by other transporters 84, 85 . As a consequence of the deficient recycling of serotonin by its transporter, serotonin synthesis and turnover are increased across brain regions in Slc6a4 -/-mice, with the greatest increase in female mice 58 . Dopaminergic neurons in the substantia nigra accumulate excess serotonin in Slc6a4 -/-mice through the dopamine transporter 84 . furthermore, expression of the organic cation transporters OCT1 and OCT3, which are also low-affinity transporters of monoamines, is increased 53, [84] [85] [86] , indicative of some partial but inefficient attempt at compensation through heterologous transporters. Slc6a4 +/-mice have fewer specific SERT binding sites (sites to which a labelled ligand for SERT binds), decreased serotonin clearance and elevated extracellular serotonin levels; however, they have unchanged tissue serotonin concentrations in the brain and in the periphery and have unchanged brain serotonin synthesis and turnover 17, 58, 73, 83 . Thus the loss of one Slc6a4 allele leads to a decrease in transporter function, but a single copy of Slc6a4 is adequate to maintain overall tissue serotonin homeostasis.
The spontaneous firing rate of serotonergic neurons in the dorsal raphe of anesthesized Slc6a4 -/-mice is ~35% of that of wild-type control mice, with intermediate values (~60%) in Slc6a4 +/-mice 69 . In addition, the time required for CA3 hippocampal neurons to return to normal firing rates following microiontophoretic application of serotonin is prolonged. This probably represents the failure of the rapid clearance of serotonin, as has been documented in the CA3 hippocampal region 69, 73 . As expected, the SSRI paroxetine further increased the serotonin-induced prolongation of hippocampal neuron recovery time in Slc6a4 +/-mice 69 . 5-HT 1A receptors in the brainstem raphe area are substantially (>60%) decreased in Slc6a4 -/-female mice, with somewhat smaller reductions in males and intermediate values in Slc6a4 +/-mice. female but not male Slc6a4 -/-mice also show modest reductions in 5-HT 1A receptors in the hypothalamus and in some areas of the amygdala and septum, but show no changes in the cortex or hippocampus 36, 37, 87, 88 . Thus, Slc6a4
+/-and Slc6a4 -/-mice display a downregulation of 5-HT 1A receptors at presynaptic somatodendritic sites, accompanied by insensitivity of these receptors and of 5-HT 1A -mediated neuroendocrine responses. This is similar to the changes that are observed in rodents chronically treated with SSRIs. cell-body groups in the nine raphe nuclei, B1-B9. The more caudal nuclei (B1-B3) in the medulla project axons to the spinal cord and the periphery, whereas the more rostral raphe nuclei contain the principal dorsal raphe groups (B6 and B7; depicted in yellow) and the median raphe groups (B5 and B8; depicted in green), which project to different but overlapping brain areas. b | Serotonin also functions in the enteric nervous system (ENS), the hypothalamo-pituitary-adrenocortical (HPA) system, the adrenomedullary neuroendocrine serotonin system (NSS) and the peripheral serotonin system (PSS), which includes the lungs, the heart, the blood vessels, the pancreas and platelets 36, 37, 43, 78, 130, 131 . DRN, dorsal raphe nucleus; MFB, medial frontal bundle; MRN, median raphe nucleus. Nature Reviews | Neuroscience .
Relevance for murine and human disease As described above, serotonin functions as both a shortrange neurotransmitter and a long-range signalling modulator, with multiple effects on whole-organism functions across many species 4, 92, 93 . This extensive pleiotropy is clearly demonstrated in this Review of the multiple mouse phenotypes that result from a single gene alteration (of Slc6a4). Short-range serotonin signals (within nanometer distances inside synapses) activate pre-and postsynaptic serotonin receptors 94 . Long-range signals are mediated by hormone systems both locally, within tissues that express SERT (such as the adrenal gland 43, 44 ), and through changes in plasma hormone levels. Additionally, blood serotonin, which circulates within platelets and is released into microcirculatory beds of capillaries and arterioles, can regulate regional blood flow 95 ; thus, the absence of serotonin in the platelets and blood of Slc6a4 -/-mice might contribute to the widespread reductions in brain glucose utilization that are observed 35 . Many of the phenotypes that have been discovered in this SERT-targeted mouse have also been glimpsed in studies that examined the association of human diseases or traits with particular human SLC6A4 variants, such as those involving the 5-HTTLPR (including the SNPs rs25531 and rs25532 within it), the intron-2 VNTR, and the I425V, I425L and G56A variants in SLC6A4 coding regions. The higher-functioning alleles of these variants, if their potential additive influence (FIG. 1b) were verified by analytical techniques such as those used in studies of mice 83 , could confer a four-to fivefold greater serotonin transport capacity than that of the lower-functioning alleles. furthermore, as substitution of SERT P339L for SERT 339L yields an ~80% reduction in serotonin uptake 11 , a theoretical range of differences in serotonin transport capacities across individuals could be as great as 15-to 20-fold if combinations of common and rare SLC6A4 acted together in influencing SERT expression and function.
Humans with the 5-HTTLPR short/short genotype closely resemble Slc6a4 +/-mice with regards to levels of SERT expression and function (FIG. 6) . These similarities allow predictive appraisals of phenotypes across species 3, 4, 26, 39, 48, 51 . Thus, it is no surprise to find that anxietyand depression-related personality traits and affective disorders 1, 8, 96 , alcohol and other drug dependencies 97 , sleep and temperature disorders 50, 98 , irritable bowel syndrome (IBS) 53, 99 , pulmonary hypertension and chronic obstructive pulmonary disease 57, 100 are associated with SLC6A4 variants in humans and other species, especially when interactions between SLC6A4 and life stress are taken into account 9, 22, 101, 102 . Some of the human disorders that have been found to be associated with SLC6A4 have not yet been investigated in Slc6a4 -/-and Slc6a4 +/-mice, for example, SIDS and myocardial infarction 103, 104 . Likewise, some of the Slc6a4 -/-mouse phenotypes, including the obese and type-2-diabetic phenotypes, have yet to be studied for SLC6A4-variant frequency distortions in cohorts of human patients; this would seem to be a high priority for investigation.
A genetic contribution to temperament and behavioural traits, including anxiety, dominance and alcohol and drug preferences, has been established in humans and several other species, probably reflecting selective forces among our ancestors. Recent research efforts in this area have therefore been focused on non-human primates, especially rhesus macaques, and are currently proceeding towards the elaboration of an interdisciplinary perspective that will blend behavioural genetics and evolutionary psychology, as well as cognitive and social neuroscience 105 . In this non-human-primate model, environmental influences might be less complex and thus less likely to confound associations between behaviour and genes. Maternal-separation studies in rhesus macaques have demonstrated that genes and environment interact to produce effects on the association of central serotonin turnover and behavioural traits, including stress reactivity and alcohol preference and dependence, with a repeat-length variation that is orthologous to the human 5-HTTLPR 106, 107 . This is in keeping with the notion that the 5-HTTLPR might influence the risk for affective and other behavioural disorders through gene-environment interactions, although the molecular and neural mechanisms that underlie the interplay of genes and environmental adversity constituting disease risk remain incompletely understood 9, 22, 101, 102, 108 . finally, gene-gene interactions have been studied in models in which Slc6a4-mutant mice have been interbred with mice that lacked either one or both copies of the dopamine transporter gene (Slc6a3), the noradrenalinetransporter gene (Slc6a2), the MAOA gene (Maoa), the 5-HT 1B -receptor gene (Htr1b) or the BDNf gene (Bdnf ), with consequent amplified, reduced or qualitatively different new phenotypes resulting 23, 34, 48, 66, 75, 109 . These studies of 'experimental epistasis' complement those in which the Slc6a4 knockout was placed on congenic C57BL/6J or 129S6 background strains to yield more subtle SERT-related phenotype differences 23 .
Evolutionary aspects of sERt biology
This Review of the consequences of an engineered change in one murine gene, Slc6a4, documents over 50 phenotypic alterations. This seemingly marked interference with nature could be considered only an artefactual curiosity in light of its production by several types of drastic genetic engineering 17, 18, 20, 21 . However, the findings in fact provide a partial delineation of all of the genetically influenced serotonergic traits that are regulated by SERT in mice. Additionally they provide a glimpse and, maybe, a preview of what is being discovered in humans with SLC6A4 variants. Most of these murine traits are altered by the loss of a single Slc6a4 allele -the changes often being intermediate to those that are produced by full knockout of the gene. furthermore, the attendant changes in expression levels (~50% decrease) and function of murine SERT are similar to those that result from 5-HTTLPR variation and related polymorphisms in human and rhesus SLC6A4 (FIG. 6) . This indicates that pleiotropy with some similarities to that found in mice is likely to exist not only in humans and non-human primates but also in other species, including other rodents, flies and worms that have known spontaneous or targeted genetic variation of the serotonergic pathway 106, [110] [111] [112] . Indeed, as discussed above, many conditions that are clearly analogous to those that arise in the Slc6a4 +/-and Slc6a4 -/-mice have been reported in studies of human medical disorders.
It is evident that some of the consequences of this engineered Slc6a4 mutation are the result of changes that occur downstream in the serotonergic systems 17, 51, 70, 73, 83 . However, other consequences, although generally relatable to altered availability of serotonin and reduced or absent SERT, seem to be qualitatively distinct traits. for instance, it is hard to immediately relate bone, heart, lung, bladder and gut structural and functional changes to alterations in aggression or the startle reflex, or to preferences for alcohol, MDMA and cocaine -although a psychosomatocist might give it a try. Thus, multiple mechanisms, some going beyond those that have already been documented 17, 69, 70, 73, 83 , are predicted by this pleiotropy.
from the most global point of view, the preponderance of changes resulting from the engineered reduction in SERT can be considered deleterious. Differences in SERT expression and function have not yet been studied across mouse species to specifically evaluate how they alter global fitness, and it is clear that more is now known about SLC6A4 variants in humans and nonhuman primates than about murine Slc6a4 mutational consequences in the real world.
Although the mouse Slc6a4 and the human SLC6A4 possess a similar set of three splice variants 113, 114 , other rodents and many non-human primates possess a more basic regulatory region. furthermore, humans seem to have multiple and more complex regulatory elements that are capable of providing both a broader range of and a more finely tunable regulatory capacity for SERT expression and function, as reflected in the 5-HTTLPR variants, the rs25531 and rs25532 SNPs and the intron-2 VNTR, as well as the rarer functional elements (for example, the I425V variant) 4 . One could speculate that this more finely tuned regulatory capacity of SERT is another example of evolution-based development, like primate and human brain development, serving to enhance fitness to succeed in subsequent eons; however, more data are needed to confirm this.
The coding region of SLC6A4 has changed over evolutionary time 4 , but the non-coding regulatory regions of the gene have not yet been carefully evaluated for such changes beyond the few examples mentioned in this review 16 . Similarly, no attempt has yet been made to quantitate SERT expression and function in relation to fitness in more complex and thus relatively 'higher' organisms, for example, chimpanzees and rhesus macaques. SERT is also present in 'simple' organisms
